LIFE - aTyr Pharma GAAP EPS of -$0.46 in-line November, 10 2022 04:02 PM aTyr Pharma Inc. aTyr Pharma press release ( NASDAQ: LIFE ): Q3 GAAP EPS of -$0.46 in-line. Cash, restricted cash, cash equivalents and investments as of September 30, 2022, were $79.6 million For further details see: aTyr Pharma GAAP EPS of -$0.46 in-line